Savvy Trades and Investments

[apatel1]

Hi Wade & R59,

I asked this question to a poster on another Board who follows this stock very closely for the last few years and this is his response:

"Back on the Q3 2014 conference call, which took place on 27 March 2014, the company stated that they only sell the high dose bolus Aggrastat and that this higher dosage is the new standard. They no longer sell the original label.

So, there should be no effect from that upcoming patent expiration"

Hope this helps
apatel